DK0621037T3 - Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler - Google Patents

Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler

Info

Publication number
DK0621037T3
DK0621037T3 DK94105958T DK94105958T DK0621037T3 DK 0621037 T3 DK0621037 T3 DK 0621037T3 DK 94105958 T DK94105958 T DK 94105958T DK 94105958 T DK94105958 T DK 94105958T DK 0621037 T3 DK0621037 T3 DK 0621037T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
pyridopyrimidinedions
preparation
methods
compound
Prior art date
Application number
DK94105958T
Other languages
English (en)
Inventor
Harald Dr Furrer
Dirk Dr Seiffge
Ismahan Dr Okyayuz-Baklouti
John Joseph Dr Grome
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0621037T3 publication Critical patent/DK0621037T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK94105958T 1993-04-23 1994-04-18 Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler DK0621037T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313317 1993-04-23

Publications (1)

Publication Number Publication Date
DK0621037T3 true DK0621037T3 (da) 2000-01-17

Family

ID=6486199

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94105958T DK0621037T3 (da) 1993-04-23 1994-04-18 Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler

Country Status (8)

Country Link
US (1) US5556854A (da)
EP (1) EP0621037B1 (da)
JP (1) JP3483160B2 (da)
AT (1) ATE181832T1 (da)
DE (1) DE59408453D1 (da)
DK (1) DK0621037T3 (da)
ES (1) ES2134284T3 (da)
GR (1) GR3031267T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334389A (en) * 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
ID25589A (id) 1998-02-27 2000-10-19 Sankyo Company Ltd Cs Senyawa-senyawa amino siklik
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
PA8539401A1 (es) * 2001-02-14 2002-10-28 Warner Lambert Co Quinazolinas como inhibidores de mmp-13
US6825180B2 (en) 2001-05-18 2004-11-30 Cell Therapeutics, Inc. Pyridopyrimidine compounds and their uses
AU2003251869A1 (en) * 2002-07-15 2004-02-02 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
WO2013115884A2 (en) * 2011-11-15 2013-08-08 Trustees Of Boston University Pyridopyrimidinone inhibitors of viruses
AU2017310529B2 (en) * 2016-08-12 2021-08-19 Edwin J. Iwanowicz Protein kinase regulators
AU2020228047A1 (en) 2019-02-27 2021-09-30 Madera Therapeutics, LLC Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA762455A (en) * 1962-03-22 1967-07-04 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Pyrido-pyrimidines

Also Published As

Publication number Publication date
EP0621037B1 (de) 1999-07-07
ATE181832T1 (de) 1999-07-15
DE59408453D1 (de) 1999-08-12
EP0621037A1 (de) 1994-10-26
JP3483160B2 (ja) 2004-01-06
ES2134284T3 (es) 1999-10-01
US5556854A (en) 1996-09-17
GR3031267T3 (en) 1999-12-31
JPH06321944A (ja) 1994-11-22

Similar Documents

Publication Publication Date Title
NO931056D0 (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
DK0625505T3 (da) 2- Cyano-1,3-dion-derivater samt deres anvendelse som herbicider
BR0109703A (pt) Derivados de piperazina
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
FI925549A (fi) Nya azaheterocyklylmetyl-kromaner
DK0625508T3 (da) Svovlholdige derivater af 2-cyano-1,3-dioner samt deres anvendelse som herbicider
DK0404283T3 (da) 11alfa-aryl-4-estrener, fremgangsmåde til fremstilling af disse samt deres anvendelse som lægemidler
ATE110071T1 (de) Pyridazinon-derivate und diese enthaltende pharmazeutische zubereitungen.
DK0509398T3 (da) Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse
ES2145818T3 (es) Utilizacion de la (s)-(-)-alfa-etil-2-oxo-1-pirrolidin-acetamida para la preparacion de medicamentos destinados al tratamiento de la ansiedad.
DK0621037T3 (da) Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
AU670491B2 (en) Pharmaceutical for the treatment of skin disorders
NO922934L (no) Cykloheksan- og tetrahydropyranderivater
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
NO882113D0 (no) Substituerte vinylcefalosporiner, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel.
NO933521D0 (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-n-oksyder, fremgangsmaater for deres fremstilling og deres anvendelse som legemiddel
FI890173A (fi) Isoxazoler med nootropisk verkan.
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
FI941850A (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö
ES2068040T3 (es) Sales de 3-(cis-2,6-dimetilpiperidino)-sidnonimina.
ES2141228T3 (es) Derivados del benzopirano.
NO924472D0 (no) Nikotinylalanin som terapeutisk middel med virkning paa sentralnervesystemet